Sage Journals: Discover world-class research

Abstract

Lymphangiogenesis, the formation of new lymphatics, is associated with chronic inflammation and tissue injury, and its role is to enhance lymphatic flow, immune cell transport, and antigen clearance. It is unknown if lymphangiogenesis takes place during periodontal disease development, and we hypothesized that growth of lymphatic vessels occurs in gingiva during development of periodontitis in mice. Inflammation was induced in gingiva with Porphyromonas gingivalis gavage, and bone resorption was verified after 42 days. Growth of lymphatic and blood vessels was measured after immunofluorescent staining with LYVE-1 and CD31. Expression of vascular endothelial growth factors and 2 inflammatory cytokines was investigated 10 days post-infection. Gingival lymphangiogenesis was found 10 days and 42 days post-infection, but proliferation of vessels was observed only in the shortest observation period. Epithelial expression of vascular growth factors (VEGF) A, C, and D was observed in gingiva, and increased numbers of immune cells expressing VEGF-C were found after infection, along with up-regulation of IL-1β and TNF-α at protein levels. We conclude that lymphangiogenesis takes place in gingiva during periodontal disease development, and that up-regulation of vascular growth factor C in recruited immune cells is likely important for the growth of lymphatic vessels.

Keywords

lymphatic growth factors angiogenesis periodontal infection cytokines gingiva

Get full access to this article

View all access options for this article.

References

Achen

Jeltsch

Kukk

Makinen

Vitali

Wilks

. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.

Alitalo

Tammela

Petrova

(2005). Lymphangiogenesis in development and human disease. Nature 438:946-953.

Artese

Piattelli

de Gouveia Cardoso

Ferrari

Onuma

Piccirilli

. (2010). Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol 81:718-726.

Baker

Evans

Roopenian

(1994). Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 39:1035-1040.

Baluk

Tammela

Ator

Lyubynska

Achen

Hicklin

. (2005). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115:247-257.

Baluk

Yao

Feng

Romano

Jung

Schreiter

. (2009). TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119:2954-2964.

Berggreen

Haug

Mkonyi

Bletsa

(2009). Characterization of the dental lymphatic system and identification of cells immunopositive to specific lymphatic markers. Eur J Oral Sci 117:34-42.

Cueni

Detmar

(2006). New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 126:2167-2177.

George

Tutton

Janssen

Arnaout

Abulafi

Eccles

. (2001). VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3:420-427.

10.

Graves

Oskoui

Volejnikova

Naguib

Cai

Desta

. (2001). Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 80:1875-1879.

11.

Grenier

(2011). Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article. Curr Drug Targets 12:322-331.

12.

Isogai

Isogal

Kimura

Fujii

Takagi

Hirose

. (1996). In vivo induction of apoptosis and immune responses in mice by administration of lipopolysaccharide from Porphyromonas gingivalis. Infect Immun 64:1461-1466.

13.

Jeltsch

Kaipainen

Joukov

Meng

Lakso

Rauvala

. (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425; erratum in Science 277:463, 1997.

14.

(2006). Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol 4:83-100.

15.

Johansson

Kalfas

(1998). Characterization of the proteinase-dependent cytotoxicity of Porphyromonas gingivalis. Eur J Oral Sci 106:863-871.

16.

Joukov

Sorsa

Kumar

Jeltsch

Claesson-Welsh

Cao

. (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911.

17.

Kataru

Jung

Jang

Yang

Schwendener

Baik

. (2009). Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650-5659.

18.

Liersch

Detmar

(2007). Lymphangiogenesis in development and disease. Thromb Haemost 98:304-310.

19.

Makinen

Veikkola

Mustjoki

Karpanen

Catimel

Nice

. (2001). Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-4773.

20.

Maruyama

Cursiefen

Jackson

Keino

Tomita

. (2005). Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363-2372.

21.

Maruyama

Asai

Thorne

Losordo

D’Amore

(2007). Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170:1178-1191.

22.

Mkonyi

Bletsa

Fristad

Wiig

Berggreen

(2010). Importance of lymph vessels in the transcapillary fluid balance in the gingiva studied in a transgenic mouse model. Am J Physiol Heart Circ Physiol 299:H275-H283.

23.

Mouta

Heroult

(2003). Inflammatory triggers of lymphangiogenesis. Lymphat Res Biol 1:201-218.

24.

Paavonen

Puolakkainen

Jussila

Jahkola

Alitalo

(2000). Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499-1504.

25.

Pihlstrom

Michalowicz

Johnson

(2005). Periodontal diseases. Lancet 366:1809-1820.

26.

Ristimaki

Narko

Enholm

Joukov

Alitalo

(1998). Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.

27.

Sasaki

Okamatsu

Kawai

Kent

Taubman

Stashenko

(2004). The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 39:432-441.

28.

Tammela

Alitalo

(2010). Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460-476.

29.

Trompezinski

Berthier-Vergnes

Denis

Schmitt

Viac

(2004). Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp Dermatol 13:98-105.

30.

Wirzenius

Tammela

Uutela

Odorisio

Zambruno

. (2007). Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204:1431-1440.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.21 MB

0.00 MB